Jiangxi Jemincare Group Launches Omalizumab Biosimilar CMAB007 in China for Asthma and Dermatology
Jiangxi Jemincare Group has overseen the official launch and first prescription of its omalizumab biosimilar,...
Jiangxi Jemincare Group has overseen the official launch and first prescription of its omalizumab biosimilar,...
Zhejiang Doer Biologics Co., Ltd, a China-based clinical-stage biopharmaceutical company, has announced a significant licensing...
US-based C4 Therapeutics Inc., (NASDAQ: CCCC) has announced receiving clinical trial approval from the US...
China-based Zai Lab Ltd (NASDAQ: ZLAB; HKG: 9688) has announced that the National Medical Products...
China-based Sino Medical Sciences Technology Inc., (SHA: 688108) has announced receiving market approval for its...
Jiangsu Hengrui Pharmaceuticals Co., Ltd (SHA: 600276), a China-based pharmaceutical company, has announced receiving approval...
China-based Everest Medicines (HKG: 1952) has announced the signing of a memorandum of understanding (MoU)...
China-based BeiGene (NASDAQ: BGNE, HKG: 6160, SHA: 688235) has announced an exclusive option and licensing...
Germany-based pharmaceutical giant Bayer (ETR: BAYN) has entered its fourth phase of partnership with the...
China-based Transcenta Holding Ltd has reported receiving clinical trial approvals from China’s Center for Drug...
Japan-based Pentax Medical, a division of the Hoya Group specializing in endoscopic products, has announced...
Jiangsu-based Contract Development and Manufacturing Organization (CDMO) Sinopep-Allsino Biopharmaceutical Co., Ltd has revised its proposal...
Gene therapy specialist Shanghai BDgene Technology Co., Ltd has announced receiving approval from the US...
Ningbo-based structural heart disease intervention device manufacturer, Jenscare Scientific Co., Ltd (HKG: 9877), has announced...
China-based Broncus Medical Inc., (HKG: 2216), a provider of precision intervention solutions focused on lung...
The Hainan Boao Lecheng International Medical Tourism Pilot Zone has entered into a strategic partnership...
China-based HutchMed Ltd (NASDAQ: HCM; HKG: 0013) has announced the initiation of a Phase I...
China-based GenScript Biotech Corporation (HKG: 1548) has announced the expansion of its current Good Manufacturing...
China-based Jacobio Pharma (HKG: 1167) has announced receiving RMB 150 million (USD 20.7 million) in...
Singapore-based Genesis MedTech has announced that it has received market approval in China for its...